IVM doesn’t get nearly enough airtime in fertility conversations, and that’s a problem. Not because it’s right for everyone, but because for the patients it suits, it’s a genuinely better option than standard IVF, and most of them never hear about it.
The reason it stays under the radar is partly industry inertia. IVF with heavy stimulation is the established workflow. Labs are set up for it, protocols are standardised, and clinics are comfortable with it. IVM requires a different skill set, a different lab capability, and a willingness to move away from the default. Not every centre offers it well. Some don’t offer it at all.
If you have PCOS, if you’ve had or are at risk of ovarian hyperstimulation syndrome (OHSS), or if you simply want to understand all of your options before committing to a full stimulation cycle, the information is worth reading carefully.
Understanding IVM
IVM stands for In Vitro Maturation. The concept is straightforward: instead of stimulating the ovaries heavily with injections to produce mature eggs, immature eggs are collected from the ovaries with minimal or no hormonal stimulation and then matured in the laboratory before fertilisation.
In standard IVF, eggs must be mature at the point of retrieval, which is why 10–14 days of gonadotropin injections are used to push follicles to full development. In IVM, that maturation step is moved from the body to the lab. The eggs are retrieved while still immature, cultured in a specially prepared medium for 24–48 hours, and then fertilised once maturation is confirmed.
The result: the same end goal, an embryo ready for transfer, achieved with a fraction of the hormonal load.
This is not an experimental technique. IVM has been performed clinically since the 1990s. The first IVM baby was born in 1991. What has changed significantly in the past decade is the laboratory science behind egg maturation media, which has improved IVM outcomes considerably and brought success rates much closer to conventional IVF for appropriate candidates.
Who Can Benefit From IVM Treatment?
IVM is not a universal alternative to IVF. It works best for a specific patient profile, and being honest about that matters.
Women with PCOS are the strongest candidates. This scenario is where IVM for PCOS patients has the most compelling clinical case. Women with polycystic ovarian syndrome typically have a high antral follicle count, meaning many small follicles are present in the ovaries at any given time. That’s a liability in standard IVF, where heavy stimulation in a PCOS ovary dramatically increases OHSS risk. In IVM, that same abundance of follicles becomes an asset. More immature eggs can be retrieved with minimal stimulation, giving the lab more material to work with without the physiological risk.
Women with a history of OHSS or high OHSS risk benefit significantly. OHSS, in its severe form, can mean hospitalisation, abdominal pain, fluid accumulation, and, in rare cases, serious complications. It is one of the most preventable serious adverse events in fertility treatment, and IVM largely eliminates the risk.
Women who cannot tolerate hormonal stimulation for medical reasons, including certain estrogen-sensitive conditions, are also candidates worth evaluating for IVM.
Women seeking a low stimulation IVF alternative on philosophical or practical grounds, including those who prefer a more natural approach or who have had a difficult experience with a heavily stimulated cycle, are worth discussing IVM with.
Where IVM is generally not the right fit: women with low antral follicle counts, women with poor ovarian reserve, or older patients where egg quality is already a primary concern. In those cases, maximising the number of mature eggs retrieved through conventional stimulation is usually more important than reducing the hormonal load.
It’s important to understand that the most effective fertility treatment is determined by experts following a comprehensive evaluation.
Two Scenarios That Show When IVM Changes Everything
Consider a hypothetical patient profile: a 29-year-old with confirmed PCOS, an antral follicle count of 28, and an AMH of 6.1 ng/mL. In a standard IVF protocol, that ovarian profile would require very careful, low-dose stimulation with intensive monitoring to avoid OHSS, and it would still carry real risk. In an IVM protocol, immature eggs are retrieved with minimal prior medication. The maturation happens in the lab. The patient avoids high-dose gonadotropins entirely. The outcome, embryos available for transfer, is achieved more safely and at considerably lower physical cost than standard IVF would mean for this specific profile.
Now consider the opposite: a hypothetical 37-year-old with a moderate ovarian reserve (AMH of 1.9 ng/mL, AFC of 11) and unexplained infertility after three failed IUI cycles. IVM is discussed at consultation. The recommendation is against it. With a moderate reserve and no PCOS, the potential benefit of avoiding stimulation is outweighed by the value of recruiting every available follicle through a controlled protocol. For this profile, conventional IVF gives more mature eggs, better selection, and a higher probability of success per cycle. IVM is not the answer for everyone, and a clinic that recommends it regardless of profile is worth questioning.
In Vitro Maturation vs IVF: A Direct Comparison
When patients weigh up in vitro maturation vs. IVF, the comparison usually focuses on stimulation. That’s the right place to focus. Here’s how they differ across the variables that actually matter:
| Factor | IVM | Conventional IVF |
| Hormonal stimulation | Minimal or none | 10–14 days, high-dose injections |
| OHSS risk | Very low | Moderate to high (PCOS profiles) |
| Egg retrieval timing | Immature eggs, earlier | Mature eggs after full stimulation |
| Lab requirement | Specialised maturation media | Standard IVF lab |
| Cycle length | Shorter (less stimulation phase) | 4–6 weeks typical |
| Cost | Generally lower than IVF | Higher (medications are a major cost driver) |
| Best suited for | PCOS, OHSS risk, high AFC | Low AFC, poor reserve, older patients |
One thing the table doesn’t capture: the physical experience. Women who have been through a heavily stimulated IVF cycle often describe the two weeks of injections, the bloating, the mood shifts, and the constant monitoring appointments as more draining than the retrieval itself. IVM removes most of that. For patients who have been through standard IVF and found it grueling, that matters.
IVM Success Rates: What’s Realistic
The IVM success rate question deserves a direct answer without hedging.
In appropriately selected patients, particularly younger women with PCOS and high antral follicle counts, IVM pregnancy rates per transfer are broadly comparable to age-matched IVF outcomes. Studies published in leading reproductive medicine journals report live birth rates of 30–40% per transfer cycle in PCOS patients under 35, which is within the range of what standard IVF delivers for the same population.
IVM’s success rate declines more sharply with age than IVF’s, as the procedure depends on egg quality that stimulation cannot enhance. This is precisely why patient selection matters so much. A 28-year-old with PCOS and an IVM success rate of 35% per transfer is a genuinely good outcome. A 41-year-old with diminished reserve attempting IVM is working against the biology in a way that conventional IVF, despite its limitations at that age, at least partially addresses through intensive stimulation.
Where IVM success rates have improved most noticeably is in laboratory technique. The culture media used to mature eggs in vitro have become significantly more sophisticated over the past decade. The gap between IVM and IVF outcomes in appropriate candidates has narrowed considerably as a result. IVM fertility treatment in India at centres with dedicated IVM laboratory capability now produces outcomes that would not have been achievable even five years ago.
What IVM Treatment in Hyderabad Actually Involves
For patients who are excellent candidates, here’s what the process looks like:
Minimal preparation phase: A short course of FSH priming (or in some protocols, no stimulation at all) over 3–5 days to encourage follicle recruitment without driving full maturation.
Ultrasound monitoring: A baseline scan and one or two monitoring scans, far fewer than a standard IVF cycle requires.
Egg retrieval: Similar to IVF, a needle aspiration under sedation, typically taking 15–20 minutes. Because follicles are smaller than in a stimulated cycle, the procedure requires a slightly modified technique.
Laboratory maturation: Retrieved immature eggs are placed in specialised maturation medium and incubated for 24–48 hours. Maturity is assessed before fertilisation proceeds.
Fertilisation via ICSI: Because the zona pellucida of an IVM-matured egg is slightly harder than in a naturally mature egg, ICSI is used for fertilisation rather than conventional IVF insemination.
Embryo culture and transfer: Identical to standard IVF from this point. Embryos are cultured to the blastocyst stage where possible, with transfer or vitrification following.
IVM treatment in Hyderabad at 9M Fertility is offered as part of a full diagnostic assessment. The decision is made based on ovarian reserve markers, AFC, AMH, and clinical history, not as a default for patients with PCOS or as an upsell based on patient preference for a “lighter” protocol.
The Part Most Clinics Don’t Tell You
IVM is not available at every fertility centre. It requires embryologists specifically trained in immature egg handling and maturation, and culture media that not all labs stock or use correctly. This is one reason why the treatment is underused relative to how many patients would benefit from it.
When evaluating whether a clinic can genuinely offer IVM, the right question is not “do you offer IVM?” but “how many IVM cycles have your embryologists performed, and what is your maturation rate per retrieved egg?” A maturation rate below 60% for immature eggs suggests either poor patient selection or suboptimal lab technique. A well-run IVM programme should achieve 70–80% maturation rates in appropriate candidates.
At 9M Fertility, IVM is offered within a programme that includes pre-cycle counselling on whether IVM or conventional IVF is clinically appropriate, not a choice left entirely to patient preference. For PCOS patients especially, the conversation about IVM is one we believe every patient deserves to have before committing to a heavily stimulated cycle.
Not a Compromise. A Different Tool.
The framing of IVM as a “gentler alternative” is accurate but slightly undersells it. For the right patient, IVM isn’t a softer version of IVF. It’s a more appropriate version of IVF. The gentleness is a feature, not a trade-off.
The patients most likely to benefit from IVM fertility treatment in India are often the same patients most at risk from conventional IVF, specifically PCOS patients facing genuine OHSS risk. For them, choosing IVM isn’t settling for less. It’s the better clinical decision.
If you have PCOS, a high antral follicle count, or a history of OHSS, ask about IVM before your clinic defaults to a standard stimulation protocol. The answer you get will tell you something useful about how they approach treatment.
Book a consultation at 9M Fertility to find out whether IVM is right for your specific profile.
→ Also read: IVF vs ICSI: Which Fertility Treatment Is Right for You?
→ Also read: PGT-A Testing: How Genetic Screening Can Improve Your IVF Success Rate
